Details of the Drug
General Information of Drug (ID: DMSFXEO)
| Drug Name |
(2R,5R)-delta-methyl-alpha-acetylenic putrescine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
6-Heptyne-2,5-diamine; Methylacetylenic putrescine; Methyl-acetylenicputrescine; Mdl 72175; 8-Methyl-8-acetylenic putrescine; delta-Methyl-alpha acetylene putrescine; Hept-6-yne-2,5-diamine; MDL-72175; AC1L3U4J; 81645-70-7; SCHEMBL4808395; CTK5F9486; AC1Q2832; AKOS006338563; 1-Ethynyl-4-methyl-1,4-butanediamine
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 126.2 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -0.4 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


